Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unilateral Breast Neoplasms × ribociclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 22 Neoplasms by Site 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 2 Breast Diseases 2 Unilateral Breast Neoplasms 1 Recurrence 1 Osteitis Deformans 1 Hereditary Sensory and Autonomic Neuropathies 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Breast Neoplasms, Male 1 Advanced Metastatic Breast Cancer 1

Interventions

ribociclib 1 palbociclib 1 abemaciclib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06760637 2026-03-02

FourLight-3

Pfizer

Phase 3 Recruiting

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡